SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Essex enriches and complements Emmes’ services
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
Subscribe To Our Newsletter & Stay Updated
